These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3179533)
1. Comparison of 3 chemotherapeutic regimens of short duration (6 months) in osteo-articular tuberculosis--results after 5 years. Working group on osteo-articular tuberculosis in Algeria. Hannachi MR Bull Int Union Tuberc Lung Dis; 1988 Sep; 63(3):14-5. PubMed ID: 3179533 [No Abstract] [Full Text] [Related]
2. The chemotherapy of osteo-articular tuberculosis with recommendations for treatment of children. Donald PR J Infect; 2011 Jun; 62(6):411-39. PubMed ID: 21672650 [TBL] [Abstract][Full Text] [Related]
3. Controlled therapeutic trial on three second-line chemotherapy regimens (one of short duration) in pulmonary tuberculosis. Ait-Khaled N; Benadjila H; Loucif MS; Mounedji A; Chaulet P Bull Int Union Tuberc; 1976; 51(1):95-102. PubMed ID: 1030318 [No Abstract] [Full Text] [Related]
4. [Chemotherapy of osteoarticular tuberculosis]. Maar D; Pereszlényi A; Táborská Z Acta Chir Orthop Traumatol Cech; 1984 Dec; 51(6):504-8. PubMed ID: 6524244 [No Abstract] [Full Text] [Related]
5. [Chemotherapy regimens in osteoarticular tuberculosis in children during surgical treatment stages]. Vatutina VV Probl Tuberk; 2001; (4):32-4. PubMed ID: 11523367 [TBL] [Abstract][Full Text] [Related]
6. [Short course chemotherapy for pulmonary tuberculosis. 3. Initial intensive regimens including pyrazinamide]. Suzuki T; Shimada M; Yamaguchi W; Kameda K; Okamura S; Aizawa H Kekkaku; 1983 Sep; 58(9):459-64. PubMed ID: 6663962 [No Abstract] [Full Text] [Related]
8. Short-course chemotherapy for paediatric respiratory tuberculosis: 5-year report. Swaminathan S; Raghavan A; Duraipandian M; Kripasankar AS; Ramachandran P Int J Tuberc Lung Dis; 2005 Jun; 9(6):693-6. PubMed ID: 15971400 [TBL] [Abstract][Full Text] [Related]
9. Drug-resistant tuberculosis of the brain in a two-year-old child. Mehta JB; Mejia E; Gallemore GH; Ramsey GF Tenn Med; 1998 Jul; 91(7):285-7. PubMed ID: 9659827 [No Abstract] [Full Text] [Related]
10. [Therapy of tuberculosis]. Eier A; Grass S Wien Med Wochenschr; 1994; 144(8-9):186-8. PubMed ID: 7941607 [TBL] [Abstract][Full Text] [Related]
11. [Piazofolin in treatment of osteo-articular tuberculosis]. Barigazzi PD; Delfino C Minerva Med; 1965 Sep; 56(76):3247-51. PubMed ID: 5319909 [No Abstract] [Full Text] [Related]
12. Medical therapy of bone and joint tuberculosis in 1998. Pertuiset E Rev Rhum Engl Ed; 1999 Mar; 66(3):152-7. PubMed ID: 10327494 [TBL] [Abstract][Full Text] [Related]
13. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment]. Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263 [TBL] [Abstract][Full Text] [Related]
14. [Tuberculosis of the skull]. Bürer JH; van der Heijden AH; Teertstra HJ; van der Wolk DB; Weigel HM Ned Tijdschr Geneeskd; 1986 Jan; 130(4):169-72. PubMed ID: 3951610 [No Abstract] [Full Text] [Related]
15. [Our experience in short-course treatment of tuberculosis. Results obtained by using therapeutic regimens of 6 to 8 months]. Ben Kheder A; Chabbou A; Zakhama B; Zaimi M; el Gharbi T; el Mekki L; el Gharbi B Bull Int Union Tuberc; 1985; 60(1-2):26-8. PubMed ID: 4074968 [No Abstract] [Full Text] [Related]
16. [Short-course chemotherapy of pulmonary tuberculosis and several problems concerning its use, especially in India]. Fox W Bull Int Union Tuberc; 1985; 60(1-2):44-54. PubMed ID: 3935193 [No Abstract] [Full Text] [Related]
17. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis]. Chu N; Yan B; Zhu L Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):388-91. PubMed ID: 11326873 [TBL] [Abstract][Full Text] [Related]
18. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]